Transform Your Practice with the BeVigilant™ OraFusion™ System
The BeVigilant™ OraFusion™ System provides clarity to confidently assess oral cancer risks, offering peace of mind for you and your patients, and the data to act urgently when early intervention is key.
![Michelle with green box](https://vigilantbiosciences.com/wp-content/uploads/Michelle-with-green-box.png)
![TT with green box](https://vigilantbiosciences.com/wp-content/uploads/TT-with-green-box.png)
![Product with green box](https://vigilantbiosciences.com/wp-content/uploads/Product-with-green-box.png)
How the BeVigilant™ OraFusion™ System** Works
BeVigilant™ OraFusion™ System is an easy-to-use, accurate*, semi-quantitative tool for frontline healthcare clinicians assessing potentially at-risk patients for oral cancer.
The BeVigilant™ Reader is an advanced immunochromatography reader which captures the test data and provides the results during the patient’s visit.
Created to improve outcomes through earlier intervention, the BeVigilant™ OraFusion™ System** is
![Check Mark Icon](https://vigilantbiosciences.com/wp-content/uploads/2-2.png)
ACCURATE*
Using multiple biomarkers in conjunction with clinical risk factors provides an accurate risk assessment
![Check Mark Icon](https://vigilantbiosciences.com/wp-content/uploads/2-2.png)
NON-INVASIVE
A simple saliva test eliminates the need for invasive procedures, offering ease and convenience
![Check Mark Icon](https://vigilantbiosciences.com/wp-content/uploads/2-2.png)
Fast
Delivering results in 15 minutes or less, streamlining next steps and treatment decisions.
The BeVigilant™ OraFusion™ System is patent pending and available in select markets outside the United States.
Schedule a demo to discover if the BeVigilant OraFusion System is right for your practice.
*Clinical Data on File